首頁 › 非小細胞肺癌 › 北卡羅來納州 › Charlotte
Charlotte, NC 的 非小細胞肺癌 臨床試驗
19 項針對 非小細胞肺癌 的研究正在 Charlotte（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
招募中3 期
- Novant Health Weisiger Cancer Insititute ( Site 0266), Charlotte
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
招募中3 期
- Carolinas Medical Center, Charlotte
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
招募中2 期
- Levine Cancer Institute, Charlotte
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
招募中2 期
- Atrium Health, Charlotte
Pan-tumor MRD Study
招募中觀察性研究
- Carolina Oncology Specialists, Charlotte
Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer
招募中2 期
- Atrium Health Levine Cancer, Charlotte
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
招募中1/2 期
- Carolina Biooncology Institute, Huntersville · 距離 13 英里
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
招募中3 期
- Levine Cancer Institute, Charlotte
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
招募中1/2 期
- Carolina BioOncology Institute, LLC, Huntersville · 距離 13 英里
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
招募中1/2 期
- Levine Cancer Institute - Charlotte, Charlotte
Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study
招募中觀察性研究
- Atrium Health Levine Cancer, Charlotte
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
招募中1/2 期
- Clinical Trial Site, Huntersville · 距離 13 英里
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
招募中1 期
- Carolina BioOncology Institute /ID# 232597, Huntersville · 距離 13 英里
Study of XB010 in Subjects With Solid Tumors
招募中1 期
- Carolina BioOncology Institute, Huntersville · 距離 13 英里
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
招募中1 期
- Carolina BioOncology Institute, Huntersville · 距離 13 英里
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
招募中1/2 期
- Carolina BioOncology Institute, Huntersville · 距離 13 英里
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中觀察性研究
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Atrium Health Pineville/LCI-Pineville, Charlotte
- Levine Cancer Institute-SouthPark, Charlotte
- 還有 8 項
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
招募中1/2 期
- Carolina BioOncology Institute, Huntersville · 距離 13 英里
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
招募中1 期
- Dren Investigational Site, Huntersville · 距離 13 英里
其他城市的 非小細胞肺癌 試驗
- Houston, TX145 項研究
- New York City, NY121 項研究
- Arlington, VA104 項研究
- Nashville, TN97 項研究
- Boston, MA90 項研究
- Los Angeles, CA87 項研究
- St. Louis, MO73 項研究
- Chicago, IL61 項研究
- Baltimore, MD60 項研究
- San Antonio, TX59 項研究
- Columbus, OH57 項研究
- Washington, DC55 項研究
Charlotte 的其他研究
- 癌症（所有類型）27 項研究
- 乳癌22 項研究
- 多發性骨髓瘤21 項研究
- 急性髓系白血病16 項研究
- 肥胖症16 項研究
- 過重15 項研究
- 大腸直腸癌13 項研究
- 卵巢癌12 項研究
- 心臟衰竭11 項研究
- 轉移性癌症11 項研究
- 頭頸部鱗狀細胞癌10 項研究
- 慢性阻塞性肺病9 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。